Arcutis Biotherapeutics, Inc. (ARQT): Operating Cash Flow
-$5.62M
Year ended 2025-12-31
$39.31M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$5.62M | n/m | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | -$112.16M | n/m | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | -$247.06M | n/m | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | -$257.71M | n/m | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | -$174.63M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$113.03M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$42.84M | n/m | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | -$14.09M | n/a | 2021-02-16, From 2018-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$5.62M | n/m |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$512.18M | n/m |
| MannKind Corp (MNKD) | 2025-12-31 | $18.25M | -57.1% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$42.48M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $196.93M | +4.4% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $175.05M | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$150.79M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$42.27M | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $127.04M | +22.7% |
Compare ARQT, SVA, MNKD, ARDX side by side · Screen every company in Pharmaceutical Preparations ↗